The incident user design in comparative effectiveness research
Top Cited Papers
Open Access
- 1 October 2012
- journal article
- review article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 22 (1), 1-6
- https://doi.org/10.1002/pds.3334
Abstract
Comparative effectiveness research includes cohort studies and registries of interventions. When investigators design such studies, how important is it to follow patients from the day they initiated treatment with the study interventions? Our article considers this question and related issues to start a dialogue on the value of the incident user design in comparative effectiveness research. By incident user design, we mean a study that sets the cohort's inception date according to patients' new use of an intervention. In contrast, most epidemiologic studies enroll patients who were currently or recently using an intervention when follow‐up began. We take the incident user design as a reasonable default strategy because it reduces biases that can impact non‐randomized studies, especially when investigators use healthcare databases. We review case studies where investigators have explored the consequences of designing a cohort study by restricting to incident users, but most of the discussion has been informed by expert opinion, not by systematic evidence. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.Keywords
This publication has 32 references indexed in Scilit:
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseBMJ, 2010
- Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in AdultsArchives of General Psychiatry, 2010
- Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ, 2008
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationPLoS Medicine, 2007
- Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial ResultsMedical Care, 2007
- Exposure‐time‐varying hazard function ratios in case‐control studies of drug effectsPharmacoepidemiology and Drug Safety, 2005
- Structural accelerated failure time models for survival analysis in studies with time-varying treatmentsPharmacoepidemiology and Drug Safety, 2005
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Design issues for drug epidemiologyBritish Journal of Clinical Pharmacology, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998